Cargando…
A metabolomic-based biomarker discovery study for predicting phototherapy duration for neonatal hyperbilirubinemia
BACKGROUND: Phototherapy is a recommended method for the treatment of neonatal hyperbilirubinemia. However, biomarkers for predicting the more effective duration of phototherapy prior to treatment are lacking. Therefore, we aimed to determine novel predictors for the timing of phototherapy from the...
Autores principales: | Zhu, Danying, Wang, Mingjie, Zhang, Zhongxiao, Liu, Minghua, Liu, Yiwen, Wu, Weiling, Lu, Dian, Wu, Xiaoyun, Wu, Wei, Wang, Xingyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834951/ https://www.ncbi.nlm.nih.gov/pubmed/36643669 http://dx.doi.org/10.21037/tp-22-637 |
Ejemplares similares
-
Challenges of phototherapy for neonatal hyperbilirubinemia (Review)
por: Wang, Juan, et al.
Publicado: (2021) -
Parental experiences of home phototherapy for neonatal hyperbilirubinemia
por: Pettersson, Miriam, et al.
Publicado: (2022) -
Indirect Neonatal Hyperbilirubinemia and the Role of Fenofibrate as an Adjuvant to Phototherapy
por: Shabo, Salam K., et al.
Publicado: (2023) -
Effects of Hyperbilirubinemia on Auditory Brainstem Response of Neonates Treated with Phototherapy
por: Salehi, Negin, et al.
Publicado: (2016) -
Higher ETCOc predicts longer phototherapy treatment in neonatal hyperbilirubinemia
por: Zhan, Yuan-Li, et al.
Publicado: (2023)